Key Insights
The United Kingdom diabetes care devices market is experiencing robust growth, projected to reach £84.31 million in 2025 and maintain a Compound Annual Growth Rate (CAGR) of 6.72% from 2025 to 2033. This expansion is driven by several key factors. The rising prevalence of diabetes in the UK, particularly type 2 diabetes, is a significant driver, necessitating increased demand for effective management devices. Technological advancements, such as the development of tubeless insulin pumps and continuous glucose monitoring (CGM) systems, offer improved patient convenience and better glycemic control, thus fueling market growth. Furthermore, increased healthcare spending and government initiatives promoting diabetes management contribute positively to market expansion. The segment encompassing insulin pumps, including both tethered and tubeless varieties, is expected to dominate the market due to their efficacy in regulating blood glucose levels. However, high costs associated with advanced technologies like CGM and insulin pumps present a restraint, potentially limiting accessibility for certain patient demographics. The market is segmented by component (insulin pumps, pens, monitoring devices), end-user (hospitals/clinics, home/personal use), and technology (tethered vs. tubeless pumps). Key players such as Medtronic, Abbott Diabetes Care, and Novo Nordisk are shaping market competition through innovation and strategic partnerships. Future growth is anticipated to be significantly influenced by the continuous improvement in device accuracy, convenience, and integration with digital health platforms.
The UK market's regional breakdown shows varying adoption rates across England, Wales, Scotland, and Northern Ireland. Variations in healthcare infrastructure and patient awareness levels likely contribute to these regional differences. While precise regional data is unavailable, future market analysis should focus on evaluating disparities in access and utilization of devices across these regions to inform targeted strategies for improving diabetes care outcomes. Further research is needed to understand the specific impact of different government policies and healthcare initiatives on the market in each region. Increased collaboration between healthcare providers, technology companies, and patient advocacy groups is crucial for improving affordability and expanding access to advanced diabetes care devices, enhancing the overall effectiveness of diabetes management in the UK.
United Kingdom (UK) Diabetes Care Devices Market Report: 2019-2033
This comprehensive report provides an in-depth analysis of the UK diabetes care devices market, offering valuable insights for industry professionals, investors, and stakeholders. The study period covers 2019-2033, with 2025 as the base and estimated year. The report forecasts market trends from 2025 to 2033, leveraging data from the historical period of 2019-2024. The market is segmented by component, end-user, technology and more, offering a granular view of this dynamic sector. Expect detailed analysis of key players like Terumo, Dexcom, Roche Diabetes Care, and Medtronic, along with emerging trends and opportunities within this rapidly evolving landscape.
-Diabetes-Care-Devices-Market.png)
United Kingdom (UK) Diabetes Care Devices Market Market Structure & Innovation Trends
The UK diabetes care devices market exhibits a moderately concentrated structure, with several multinational corporations holding significant market share. Companies like Medtronic, Abbott Diabetes Care, and Roche Diabetes Care dominate various segments. However, smaller, specialized companies focusing on niche technologies are also emerging, leading to increased competition. The market share distribution amongst the top 5 players is estimated at xx% in 2025. Innovation is heavily driven by advancements in continuous glucose monitoring (CGM), tubeless insulin pump technology, and integrated automated insulin delivery (AID) systems. The regulatory framework, primarily governed by the Medicines and Healthcare products Regulatory Agency (MHRA) and NICE, significantly influences market access and product approvals. Substitute products, particularly those focusing on lifestyle modifications, pose a certain degree of competitive pressure. The end-user demographics are primarily characterized by a growing aging population and increasing prevalence of type 2 diabetes. M&A activities have been moderate in recent years, with deal values primarily focusing on enhancing technology portfolios and market reach (xx Million in total deal value in 2024).
- Market Concentration: Moderate, with top 5 players holding xx% market share in 2025.
- Innovation Drivers: CGM, tubeless insulin pumps, AID systems.
- Regulatory Framework: MHRA, NICE guidelines significantly impact market access.
- Product Substitutes: Lifestyle modifications, alternative therapies.
- End-User Demographics: Aging population, increasing prevalence of type 2 diabetes.
- M&A Activity: Moderate activity, xx Million in total deal value in 2024, focused on technology and market expansion.
-Diabetes-Care-Devices-Market.png)
United Kingdom (UK) Diabetes Care Devices Market Market Dynamics & Trends
The UK diabetes care devices market is experiencing robust growth, driven by factors such as the rising prevalence of diabetes, increasing demand for advanced monitoring technologies, and improving healthcare infrastructure. The market is projected to witness a CAGR of xx% during the forecast period (2025-2033). The penetration rate of CGM systems is steadily increasing, although still below its potential given the rising number of type 1 & 2 diabetes patients. Technological disruptions, primarily through the adoption of AI-powered devices and integrated data management systems, are transforming the landscape. Consumer preferences are shifting towards more convenient, user-friendly devices with improved accuracy and less invasive procedures. Competitive dynamics are intensifying with increased investments in R&D, strategic partnerships, and new product launches. This competitive intensity is likely to remain throughout the forecast period driving innovation and improved accessibility for patients.
Dominant Regions & Segments in United Kingdom (UK) Diabetes Care Devices Market
The UK diabetes care devices market is geographically concentrated, with major urban centers and regions with high diabetes prevalence exhibiting higher demand. Within the component segment, continuous glucose monitoring (CGM) systems and insulin pumps are the fastest-growing areas due to their improved accuracy and convenience compared to traditional methods. Amongst end-users, the home/personal care segment dominates due to the increased preference for self-management of diabetes. The tubeless insulin pump technology segment is expected to witness significant growth due to improved patient compliance and comfort.
Key Drivers:
- High prevalence of diabetes
- Government initiatives to improve diabetes management
- Technological advancements
- Rising healthcare expenditure
Dominant Segments:
- Continuous Glucose Monitoring (CGM)
- Insulin Pumps (Tubeless showing fastest growth)
- Home/Personal Care segment (end-user)
United Kingdom (UK) Diabetes Care Devices Market Product Innovations
Recent innovations include advancements in CGM technology, featuring smaller, more accurate sensors with longer wear times. Tubeless insulin pumps are gaining traction, eliminating the need for cumbersome tubing, while integrated automated insulin delivery (AID) systems are beginning to emerge, offering significant improvements in glucose control. These innovations are driven by the need for improved accuracy, patient comfort, and reduced healthcare costs. The market fit for these innovations is excellent, given the increasing demand for better diabetes management tools and the significant unmet medical needs within the diabetic community.
Report Scope & Segmentation Analysis
This report segments the UK diabetes care devices market by component (Insulin Pump Device, Insulin Pump Reservoir, Infusion Set, Insulin Pens, Insulin Syringes, Jet Injectors, Self-monitoring Blood Glucose, Lancets, Continuous Glucose Monitoring), end-user (Hospital/Clinics, Home/Personal), and technology (Tethered Insulin Pump, Tubeless Insulin Pump). Each segment's growth is analyzed, providing market size estimations and competitive dynamics. The forecast projects significant growth for CGM and tubeless insulin pump technology segments due to their enhanced features and improved patient outcomes.
Key Drivers of United Kingdom (UK) Diabetes Care Devices Market Growth
The UK diabetes care devices market is propelled by the increasing prevalence of diabetes, particularly type 2, among the aging population. Technological advancements, particularly in CGM and insulin pump technologies, are driving adoption. Furthermore, supportive government initiatives and rising healthcare expenditure further bolster market expansion. The shift towards self-management and improved patient outcomes is another key factor driving growth.
Challenges in the United Kingdom (UK) Diabetes Care Devices Market Sector
Challenges include the high cost of advanced devices, potential reimbursement hurdles, and the need for improved patient education and training. Supply chain disruptions and the competitive landscape also present significant obstacles. The impact of these challenges on market growth is estimated at a xx% reduction in potential market size in 2025.
Emerging Opportunities in United Kingdom (UK) Diabetes Care Devices Market
Emerging opportunities include the expansion of telehealth services, integration of AI and machine learning in diabetes management, and the development of personalized medicine approaches. The growing adoption of digital health solutions and remote monitoring presents considerable potential.
Leading Players in the United Kingdom (UK) Diabetes Care Devices Market Market
- Terumo
- Dexcom
- Insulin Devices
- Roche Diabetes Care
- Eli Lilly
- Sanofi
- Abbott Diabetes Care
- Medtronic
- LifeScan (Johnson & Johnson)
- Becton Dickinson
- Novo Nordisk A/S
- Arkray
Key Developments in United Kingdom (UK) Diabetes Care Devices Market Industry
- May 2023: NICE guideline revision incorporating CGMs and flash glucose monitors for type 2 diabetic children. This significantly expands the market for automated glucose monitoring devices.
- April 2022: Abbott, CamDiab, and Ypsomed partner to develop an integrated automated insulin delivery (AID) system. This signals a major advancement in diabetes management technology and increased competition.
Future Outlook for United Kingdom (UK) Diabetes Care Devices Market Market
The UK diabetes care devices market is poised for sustained growth, driven by technological advancements, increasing diabetes prevalence, and supportive government policies. Strategic partnerships and investments in R&D will further accelerate market expansion, creating significant opportunities for both established and emerging players in the coming years. The focus on improved patient outcomes, convenience, and integration with digital health solutions will define the future trajectory of the market.
United Kingdom (UK) Diabetes Care Devices Market Segmentation
-
1. Management Devices
-
1.1. Insulin Pump
-
1.1.1. Technology
- 1.1.1.1. Tethered Insulin Pump
- 1.1.1.2. Tubeless Insulin Pump
-
1.1.2. Component
- 1.1.2.1. Insulin Pump Device
- 1.1.2.2. Insulin Pump Reservoir
- 1.1.2.3. Infusion Set
-
1.1.1. Technology
-
1.2. Insulin pens
- 1.2.1. Cartridges in Reusable Pens
- 1.2.2. Insulin Disposable Pens
- 1.3. Insulin Syringes
- 1.4. Jet Injectors
-
1.1. Insulin Pump
-
2. Monitoring Devices
-
2.1. Self-monitoring Blood Glucose
- 2.1.1. Glucometer Devices
- 2.1.2. Blood Glucose Test Strips
- 2.1.3. Lancets
-
2.2. Continuous Glucose Monitoring
- 2.2.1. Sensors
- 2.2.2. Durables (Receivers and Transmitters)
-
2.1. Self-monitoring Blood Glucose
-
3. End User
- 3.1. Hospital/Clinics
- 3.2. Home/Personal
United Kingdom (UK) Diabetes Care Devices Market Segmentation By Geography
- 1. United Kingdom
-Diabetes-Care-Devices-Market.png)
United Kingdom (UK) Diabetes Care Devices Market REPORT HIGHLIGHTS
| Aspects | Details |
|---|---|
| Study Period | 2019-2033 |
| Base Year | 2024 |
| Estimated Year | 2025 |
| Forecast Period | 2025-2033 |
| Historical Period | 2019-2024 |
| Growth Rate | CAGR of 6.72% from 2019-2033 |
| Segmentation |
|
Table of Contents
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 2.1. Introduction
- 3. Market Dynamics
- 3.1. Introduction
- 3.2. Market Drivers
- 3.2.1. Rising Prevalence of Cancer Worldwide; Technological Advancements in Diagnostic Testing; Increasing Demand for Point-of-care Treatment
- 3.3. Market Restrains
- 3.3.1. High Cost of Molecular Diagnostic Tests; Lack of Skilled Workforce and Stringent Regulatory Framework
- 3.4. Market Trends
- 3.4.1. Continuous Glucose Monitoring Segment is Expected to Witness a Healthy Growth Rate Over the Forecast Period
- 4. Market Factor Analysis
- 4.1. Porters Five Forces
- 4.2. Supply/Value Chain
- 4.3. PESTEL analysis
- 4.4. Market Entropy
- 4.5. Patent/Trademark Analysis
- 5. United Kingdom (UK) Diabetes Care Devices Market Analysis, Insights and Forecast, 2019-2031
- 5.1. Market Analysis, Insights and Forecast - by Management Devices
- 5.1.1. Insulin Pump
- 5.1.1.1. Technology
- 5.1.1.1.1. Tethered Insulin Pump
- 5.1.1.1.2. Tubeless Insulin Pump
- 5.1.1.2. Component
- 5.1.1.2.1. Insulin Pump Device
- 5.1.1.2.2. Insulin Pump Reservoir
- 5.1.1.2.3. Infusion Set
- 5.1.1.1. Technology
- 5.1.2. Insulin pens
- 5.1.2.1. Cartridges in Reusable Pens
- 5.1.2.2. Insulin Disposable Pens
- 5.1.3. Insulin Syringes
- 5.1.4. Jet Injectors
- 5.1.1. Insulin Pump
- 5.2. Market Analysis, Insights and Forecast - by Monitoring Devices
- 5.2.1. Self-monitoring Blood Glucose
- 5.2.1.1. Glucometer Devices
- 5.2.1.2. Blood Glucose Test Strips
- 5.2.1.3. Lancets
- 5.2.2. Continuous Glucose Monitoring
- 5.2.2.1. Sensors
- 5.2.2.2. Durables (Receivers and Transmitters)
- 5.2.1. Self-monitoring Blood Glucose
- 5.3. Market Analysis, Insights and Forecast - by End User
- 5.3.1. Hospital/Clinics
- 5.3.2. Home/Personal
- 5.4. Market Analysis, Insights and Forecast - by Region
- 5.4.1. United Kingdom
- 5.1. Market Analysis, Insights and Forecast - by Management Devices
- 6. England United Kingdom (UK) Diabetes Care Devices Market Analysis, Insights and Forecast, 2019-2031
- 7. Wales United Kingdom (UK) Diabetes Care Devices Market Analysis, Insights and Forecast, 2019-2031
- 8. Scotland United Kingdom (UK) Diabetes Care Devices Market Analysis, Insights and Forecast, 2019-2031
- 9. Northern United Kingdom (UK) Diabetes Care Devices Market Analysis, Insights and Forecast, 2019-2031
- 10. Ireland United Kingdom (UK) Diabetes Care Devices Market Analysis, Insights and Forecast, 2019-2031
- 11. Competitive Analysis
- 11.1. Market Share Analysis 2024
- 11.2. Company Profiles
- 11.2.1 Terumo
- 11.2.1.1. Overview
- 11.2.1.2. Products
- 11.2.1.3. SWOT Analysis
- 11.2.1.4. Recent Developments
- 11.2.1.5. Financials (Based on Availability)
- 11.2.2 Dexcom
- 11.2.2.1. Overview
- 11.2.2.2. Products
- 11.2.2.3. SWOT Analysis
- 11.2.2.4. Recent Developments
- 11.2.2.5. Financials (Based on Availability)
- 11.2.3 Insulin Devices
- 11.2.3.1. Overview
- 11.2.3.2. Products
- 11.2.3.3. SWOT Analysis
- 11.2.3.4. Recent Developments
- 11.2.3.5. Financials (Based on Availability)
- 11.2.4 Roche Diabetes Care
- 11.2.4.1. Overview
- 11.2.4.2. Products
- 11.2.4.3. SWOT Analysis
- 11.2.4.4. Recent Developments
- 11.2.4.5. Financials (Based on Availability)
- 11.2.5 Eli Lilly
- 11.2.5.1. Overview
- 11.2.5.2. Products
- 11.2.5.3. SWOT Analysis
- 11.2.5.4. Recent Developments
- 11.2.5.5. Financials (Based on Availability)
- 11.2.6 Sanofi
- 11.2.6.1. Overview
- 11.2.6.2. Products
- 11.2.6.3. SWOT Analysis
- 11.2.6.4. Recent Developments
- 11.2.6.5. Financials (Based on Availability)
- 11.2.7 Abbott Diabetes Care
- 11.2.7.1. Overview
- 11.2.7.2. Products
- 11.2.7.3. SWOT Analysis
- 11.2.7.4. Recent Developments
- 11.2.7.5. Financials (Based on Availability)
- 11.2.8 Medtronic
- 11.2.8.1. Overview
- 11.2.8.2. Products
- 11.2.8.3. SWOT Analysis
- 11.2.8.4. Recent Developments
- 11.2.8.5. Financials (Based on Availability)
- 11.2.9 LifeScan (Johnson & Johnson)
- 11.2.9.1. Overview
- 11.2.9.2. Products
- 11.2.9.3. SWOT Analysis
- 11.2.9.4. Recent Developments
- 11.2.9.5. Financials (Based on Availability)
- 11.2.10 Becton Dickinson
- 11.2.10.1. Overview
- 11.2.10.2. Products
- 11.2.10.3. SWOT Analysis
- 11.2.10.4. Recent Developments
- 11.2.10.5. Financials (Based on Availability)
- 11.2.11 Novo Nordisk A/S
- 11.2.11.1. Overview
- 11.2.11.2. Products
- 11.2.11.3. SWOT Analysis
- 11.2.11.4. Recent Developments
- 11.2.11.5. Financials (Based on Availability)
- 11.2.12 Arkray
- 11.2.12.1. Overview
- 11.2.12.2. Products
- 11.2.12.3. SWOT Analysis
- 11.2.12.4. Recent Developments
- 11.2.12.5. Financials (Based on Availability)
- 11.2.1 Terumo
List of Figures
- Figure 1: United Kingdom (UK) Diabetes Care Devices Market Revenue Breakdown (Million, %) by Product 2024 & 2032
- Figure 2: United Kingdom (UK) Diabetes Care Devices Market Share (%) by Company 2024
List of Tables
- Table 1: United Kingdom (UK) Diabetes Care Devices Market Revenue Million Forecast, by Region 2019 & 2032
- Table 2: United Kingdom (UK) Diabetes Care Devices Market Volume K Unit Forecast, by Region 2019 & 2032
- Table 3: United Kingdom (UK) Diabetes Care Devices Market Revenue Million Forecast, by Management Devices 2019 & 2032
- Table 4: United Kingdom (UK) Diabetes Care Devices Market Volume K Unit Forecast, by Management Devices 2019 & 2032
- Table 5: United Kingdom (UK) Diabetes Care Devices Market Revenue Million Forecast, by Monitoring Devices 2019 & 2032
- Table 6: United Kingdom (UK) Diabetes Care Devices Market Volume K Unit Forecast, by Monitoring Devices 2019 & 2032
- Table 7: United Kingdom (UK) Diabetes Care Devices Market Revenue Million Forecast, by End User 2019 & 2032
- Table 8: United Kingdom (UK) Diabetes Care Devices Market Volume K Unit Forecast, by End User 2019 & 2032
- Table 9: United Kingdom (UK) Diabetes Care Devices Market Revenue Million Forecast, by Region 2019 & 2032
- Table 10: United Kingdom (UK) Diabetes Care Devices Market Volume K Unit Forecast, by Region 2019 & 2032
- Table 11: United Kingdom (UK) Diabetes Care Devices Market Revenue Million Forecast, by Country 2019 & 2032
- Table 12: United Kingdom (UK) Diabetes Care Devices Market Volume K Unit Forecast, by Country 2019 & 2032
- Table 13: England United Kingdom (UK) Diabetes Care Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 14: England United Kingdom (UK) Diabetes Care Devices Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 15: Wales United Kingdom (UK) Diabetes Care Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 16: Wales United Kingdom (UK) Diabetes Care Devices Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 17: Scotland United Kingdom (UK) Diabetes Care Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 18: Scotland United Kingdom (UK) Diabetes Care Devices Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 19: Northern United Kingdom (UK) Diabetes Care Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 20: Northern United Kingdom (UK) Diabetes Care Devices Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 21: Ireland United Kingdom (UK) Diabetes Care Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 22: Ireland United Kingdom (UK) Diabetes Care Devices Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 23: United Kingdom (UK) Diabetes Care Devices Market Revenue Million Forecast, by Management Devices 2019 & 2032
- Table 24: United Kingdom (UK) Diabetes Care Devices Market Volume K Unit Forecast, by Management Devices 2019 & 2032
- Table 25: United Kingdom (UK) Diabetes Care Devices Market Revenue Million Forecast, by Monitoring Devices 2019 & 2032
- Table 26: United Kingdom (UK) Diabetes Care Devices Market Volume K Unit Forecast, by Monitoring Devices 2019 & 2032
- Table 27: United Kingdom (UK) Diabetes Care Devices Market Revenue Million Forecast, by End User 2019 & 2032
- Table 28: United Kingdom (UK) Diabetes Care Devices Market Volume K Unit Forecast, by End User 2019 & 2032
- Table 29: United Kingdom (UK) Diabetes Care Devices Market Revenue Million Forecast, by Country 2019 & 2032
- Table 30: United Kingdom (UK) Diabetes Care Devices Market Volume K Unit Forecast, by Country 2019 & 2032
Frequently Asked Questions
1. What is the projected Compound Annual Growth Rate (CAGR) of the United Kingdom (UK) Diabetes Care Devices Market?
The projected CAGR is approximately 6.72%.
2. Which companies are prominent players in the United Kingdom (UK) Diabetes Care Devices Market?
Key companies in the market include Terumo, Dexcom, Insulin Devices, Roche Diabetes Care, Eli Lilly, Sanofi, Abbott Diabetes Care, Medtronic, LifeScan (Johnson & Johnson), Becton Dickinson, Novo Nordisk A/S, Arkray.
3. What are the main segments of the United Kingdom (UK) Diabetes Care Devices Market?
The market segments include Management Devices, Monitoring Devices, End User.
4. Can you provide details about the market size?
The market size is estimated to be USD 84.31 Million as of 2022.
5. What are some drivers contributing to market growth?
Rising Prevalence of Cancer Worldwide; Technological Advancements in Diagnostic Testing; Increasing Demand for Point-of-care Treatment.
6. What are the notable trends driving market growth?
Continuous Glucose Monitoring Segment is Expected to Witness a Healthy Growth Rate Over the Forecast Period.
7. Are there any restraints impacting market growth?
High Cost of Molecular Diagnostic Tests; Lack of Skilled Workforce and Stringent Regulatory Framework.
8. Can you provide examples of recent developments in the market?
May 2023: The National Institute of Clinical Excellence (NICE) made a significant advancement by revising its guidelines to incorporate CGMs and flash glucose monitors, which are automated glucose monitoring devices, for children diagnosed with type 2 diabetes. This development marks a significant milestone for the United Kingdom, as it eliminates the sole reliance on fingerstick testing to monitor blood sugar levels in children. Although fingersticks have been valuable, they can induce stress and discomfort, particularly for children and their families who need to perform numerous tests daily.
9. What pricing options are available for accessing the report?
Pricing options include single-user, multi-user, and enterprise licenses priced at USD 3800, USD 4500, and USD 5800 respectively.
10. Is the market size provided in terms of value or volume?
The market size is provided in terms of value, measured in Million and volume, measured in K Unit.
11. Are there any specific market keywords associated with the report?
Yes, the market keyword associated with the report is "United Kingdom (UK) Diabetes Care Devices Market," which aids in identifying and referencing the specific market segment covered.
12. How do I determine which pricing option suits my needs best?
The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.
13. Are there any additional resources or data provided in the United Kingdom (UK) Diabetes Care Devices Market report?
While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.
14. How can I stay updated on further developments or reports in the United Kingdom (UK) Diabetes Care Devices Market?
To stay informed about further developments, trends, and reports in the United Kingdom (UK) Diabetes Care Devices Market, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.
Methodology
Step 1 - Identification of Relevant Samples Size from Population Database
Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)
Note*: In applicable scenarios
Step 3 - Data Sources
Primary Research
- Web Analytics
- Survey Reports
- Research Institute
- Latest Research Reports
- Opinion Leaders
Secondary Research
- Annual Reports
- White Paper
- Latest Press Release
- Industry Association
- Paid Database
- Investor Presentations
Step 4 - Data Triangulation
Involves using different sources of information in order to increase the validity of a study
These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.
Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.
During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence
